Search Cancer Clinical Trials

Mass General Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
Search by condition
Search By:
25 results
  • Ovarian Cancer, Cellular Therapy

24-570          Phase I

A Phase 1a/1b Study of 27T51, an anti-MUC16 CAR T cell drug product administered alone or in combination for participants with recurrent or refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer

  • Head and Neck Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Bladder Cancer, Breast Cancer, Cervical Cancer, Esophageal Cancer

24-353          Phase I

A Phase 1a/1b Study of LY4052031, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants with Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors

  • Lung Cancer, Hematology, Ovarian Cancer, Breast Cancer

19-642          Phase III

A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Chemotherapy for Treatment of Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

  • Ovarian Cancer

24-453          Phase I

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subjects with Advanced Solid Tumors

  • Ovarian Cancer, Rectal Cancer, Thymoma, Colorectal Cancer, Gastric (Stomach) Cancer, Head and Neck Cancer, Esophageal Cancer, Melanoma, Lung Cancer, Kidney Cancer

23-423          Phase I

A Phase I, Open-label, Multi-center Study of KFA115 as a Single Agent and in Combination with Pembrolizumab in Patients with Select Advanced Cancers

  • Gastric (Stomach) Cancer, Colorectal Cancer, Head and Neck Cancer, Ovarian Cancer, Metastatic/Advanced Cancer, Cervical Cancer, Breast Cancer, Endometrial Cancer

23-618          Phase I

A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-alpha Inhibitor, TOS-358, in Adult Subjects with Select Solid Tumors

  • Vulva Cancer, Uterine Cancer, Ovarian Cancer, Cervical Cancer, Breast Cancer

24-485          Phase I

AKTive-001: A Phase 1/1b Multiple Cohort Trial of ALTA2618 in Patients with Advanced Solid Tumors with AKT1 E17K Mutation

  • Pancreatic Cancer, Ovarian Cancer, Lung Cancer, Colorectal Cancer

23-242          Phase I

An Open-Label Phase 1 Dose-Escalation and Expansion Study Investigating the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of PRTH-101 Alone or in Combination with Pembrolizumab in Adults with Locally Advanced or Metastatic Solid Tumors

  • Colorectal Cancer, Ovarian Cancer, Metastatic/Advanced Cancer, Gastric (Stomach) Cancer

18-606          Phase II

FEASIBILITY OF THE LUM IMAGING SYSTEM FOR DETECTION OF PERITONEAL SURFACE MALIGNANCIES

  • Breast Cancer, Ovarian Cancer, Head and Neck Cancer, Endometrial Cancer

23-044          Phase II

First-in-Human Study of STX-478, a Mutant-Selective PI3Ka Inhibitor as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumor

Showing 11 - 20 of 25 results